Skip to main content

WATSON 3614 (Ropinirole Hydrochloride Extended-Release 8 mg)

Pill with imprint WATSON 3614 is Red, Elliptical/Oval and has been identified as Ropinirole Hydrochloride Extended-Release 8 mg. It is supplied by Watson Laboratories, Inc.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3614

Ropinirole hydrochloride extended-release 8 mg WATSON 3614
Ropinirole hydrochloride extended-release 8 mg WATSON 3614
Ropinirole hydrochloride extended-release 8 mg WATSON 3614

Ropinirole Hydrochloride Extended-Release

Imprint
WATSON 3614
Strength
8 mg
Color
Red
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3614 (Discontinued)
Inactive Ingredients
hypromelloses, mannitol, glyceryl dibehenate, lactose monohydrate, hydrogenated castor oil, povidone, sodium lauryl sulfate, magnesium silicate, magnesium stearate, silicon dioxide, triethyl citrate, titanium dioxide, polydextrose, triacetin, polyethylene glycol 8000, FD&C Yellow No. 6, aluminum oxide, FD&C Blue No. 2, FD&C Red No. 40, vinyl acetate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.